| Analysis | Samples | Factors | Units |
|---|---|---|---|
| ESI negative ion mode ( Oxylipins analysis) | HF epi 1 | Treatment:HFD | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF epi 2 | Treatment:HFD | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF epi 3 | Treatment:HFD | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF epi 4 | Treatment:HFD | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF epi 7 | Treatment:HFD | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF epi 8 | Treatment:HFD | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF Hypo 1 | Treatment:HFD | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF Hypo 2 | Treatment:HFD | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF Hypo 3 | Treatment:HFD | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF Hypo 4 | Treatment:HFD | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF Hypo 7 | Treatment:HFD | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF Hypo 8 | Treatment:HFD | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF liv 1 | Treatment:HFD | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF liv 2 | Treatment:HFD | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF liv 3 | Treatment:HFD | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF liv 4 | Treatment:HFD | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF liv 7 | Treatment:HFD | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF liv 8 | Treatment:HFD | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF mus 1 | Treatment:HFD | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF mus 2 | Treatment:HFD | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF mus 3 | Treatment:HFD | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF mus 4 | Treatment:HFD | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF mus 7 | Treatment:HFD | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF mus 8 | Treatment:HFD | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF plasma 1 | Treatment:HFD | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF plasma 2 | Treatment:HFD | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF plasma 3 | Treatment:HFD | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF plasma 4 | Treatment:HFD | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF plasma 7 | Treatment:HFD | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | HF plasma 8 | Treatment:HFD | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF epi 1 | Treatment:LFD | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF epi 2 | Treatment:LFD | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF epi 3 | Treatment:LFD | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF epi 6 | Treatment:LFD | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF epi 7 | Treatment:LFD | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF epi 8 | Treatment:LFD | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF Hypo 1 | Treatment:LFD | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF Hypo 2 | Treatment:LFD | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF Hypo 3 | Treatment:LFD | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF Hypo 6 | Treatment:LFD | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF Hypo 7 | Treatment:LFD | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF Hypo 8 | Treatment:LFD | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF liv 1 | Treatment:LFD | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF liv 2 | Treatment:LFD | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF liv 3 | Treatment:LFD | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF liv 6 | Treatment:LFD | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF liv 7 | Treatment:LFD | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF liv 8 | Treatment:LFD | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF mus 1 | Treatment:LFD | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF mus 2 | Treatment:LFD | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF mus 3 | Treatment:LFD | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF mus 6 | Treatment:LFD | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF mus 7 | Treatment:LFD | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF mus 8 | Treatment:LFD | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF plasma 1 | Treatment:LFD | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF plasma 2 | Treatment:LFD | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF plasma 3 | Treatment:LFD | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF plasma 6 | Treatment:LFD | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF plasma 7 | Treatment:LFD | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | LF plasma 8 | Treatment:LFD | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW epi 2 | Treatment:SW | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW epi 3 | Treatment:SW | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW epi 4 | Treatment:SW | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW epi 5 | Treatment:SW | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW epi 7 | Treatment:SW | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW epi 8 | Treatment:SW | Tissue Type:Adipose | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW Hypo 2 | Treatment:SW | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW Hypo 3 | Treatment:SW | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW Hypo 4 | Treatment:SW | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW Hypo 5 | Treatment:SW | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW Hypo 7 | Treatment:SW | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW Hypo 8 | Treatment:SW | Tissue Type:Hypothalmus | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW liv 2 | Treatment:SW | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW liv 3 | Treatment:SW | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW liv 4 | Treatment:SW | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW liv 5 | Treatment:SW | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW liv 7 | Treatment:SW | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW liv 8 | Treatment:SW | Tissue Type:Liver | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW mus 2 | Treatment:SW | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW mus 3 | Treatment:SW | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW mus 4 | Treatment:SW | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW mus 5 | Treatment:SW | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW mus 7 | Treatment:SW | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW mus 8 | Treatment:SW | Tissue Type:Muscle | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW plasma 2 | Treatment:SW | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW plasma 3 | Treatment:SW | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW plasma 4 | Treatment:SW | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW plasma 5 | Treatment:SW | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW plasma 7 | Treatment:SW | Tissue Type:Plasma | % Area Ratio |
| ESI negative ion mode ( Oxylipins analysis) | SW plasma 8 | Treatment:SW | Tissue Type:Plasma | % Area Ratio |
| ESI positive ion mode (Endocannabinoid analysis) | HF epi 1 | Treatment:HFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF epi 2 | Treatment:HFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF epi 3 | Treatment:HFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF epi 4 | Treatment:HFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF epi 7 | Treatment:HFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF epi 8 | Treatment:HFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF Hypo 1 | Treatment:HFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF Hypo 2 | Treatment:HFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF Hypo 3 | Treatment:HFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF Hypo 4 | Treatment:HFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF Hypo 7 | Treatment:HFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF Hypo 8 | Treatment:HFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF liv 1 | Treatment:HFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF liv 2 | Treatment:HFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF liv 3 | Treatment:HFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF liv 4 | Treatment:HFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF liv 7 | Treatment:HFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF liv 8 | Treatment:HFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF mus 1 | Treatment:HFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF mus 2 | Treatment:HFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF mus 3 | Treatment:HFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF mus 4 | Treatment:HFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF mus 7 | Treatment:HFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF mus 8 | Treatment:HFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF plasma 1 | Treatment:HFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF plasma 2 | Treatment:HFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF plasma 3 | Treatment:HFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF plasma 4 | Treatment:HFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF plasma 7 | Treatment:HFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | HF plasma 8 | Treatment:HFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF epi 1 | Treatment:LFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF epi 2 | Treatment:LFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF epi 3 | Treatment:LFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF epi 6 | Treatment:LFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF epi 7 | Treatment:LFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF epi 8 | Treatment:LFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF Hypo 1 | Treatment:LFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF Hypo 2 | Treatment:LFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF Hypo 3 | Treatment:LFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF Hypo 6 | Treatment:LFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF Hypo 7 | Treatment:LFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF Hypo 8 | Treatment:LFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF liv 1 | Treatment:LFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF liv 2 | Treatment:LFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF liv 3 | Treatment:LFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF liv 6 | Treatment:LFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF liv 7 | Treatment:LFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF liv 8 | Treatment:LFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF mus 1 | Treatment:LFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF mus 2 | Treatment:LFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF mus 3 | Treatment:LFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF mus 6 | Treatment:LFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF mus 7 | Treatment:LFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF mus 8 | Treatment:LFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF plasma 1 | Treatment:LFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF plasma 2 | Treatment:LFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF plasma 3 | Treatment:LFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF plasma 6 | Treatment:LFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF plasma 7 | Treatment:LFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | LF plasma 8 | Treatment:LFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW epi 2 | Treatment:SW | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW epi 3 | Treatment:SW | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW epi 4 | Treatment:SW | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW epi 5 | Treatment:SW | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW epi 7 | Treatment:SW | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW epi 8 | Treatment:SW | Tissue Type:Adipose | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW Hypo 2 | Treatment:SW | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW Hypo 3 | Treatment:SW | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW Hypo 4 | Treatment:SW | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW Hypo 5 | Treatment:SW | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW Hypo 7 | Treatment:SW | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW Hypo 8 | Treatment:SW | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW liv 2 | Treatment:SW | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW liv 3 | Treatment:SW | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW liv 4 | Treatment:SW | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW liv 5 | Treatment:SW | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW liv 7 | Treatment:SW | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW liv 8 | Treatment:SW | Tissue Type:Liver | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW mus 2 | Treatment:SW | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW mus 3 | Treatment:SW | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW mus 4 | Treatment:SW | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW mus 5 | Treatment:SW | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW mus 7 | Treatment:SW | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW mus 8 | Treatment:SW | Tissue Type:Muscle | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW plasma 2 | Treatment:SW | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW plasma 3 | Treatment:SW | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW plasma 4 | Treatment:SW | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW plasma 5 | Treatment:SW | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW plasma 7 | Treatment:SW | Tissue Type:Plasma | nM |
| ESI positive ion mode (Endocannabinoid analysis) | SW plasma 8 | Treatment:SW | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | HF epi 1 | Treatment:HFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | HF epi 2 | Treatment:HFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | HF epi 3 | Treatment:HFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | HF epi 4 | Treatment:HFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | HF epi 7 | Treatment:HFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | HF epi 8 | Treatment:HFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | HF Hypo 1 | Treatment:HFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | HF Hypo 2 | Treatment:HFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | HF Hypo 3 | Treatment:HFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | HF Hypo 4 | Treatment:HFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | HF Hypo 7 | Treatment:HFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | HF Hypo 8 | Treatment:HFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | HF liv 1 | Treatment:HFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | HF liv 2 | Treatment:HFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | HF liv 3 | Treatment:HFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | HF liv 4 | Treatment:HFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | HF liv 7 | Treatment:HFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | HF liv 8 | Treatment:HFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | HF mus 1 | Treatment:HFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | HF mus 2 | Treatment:HFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | HF mus 3 | Treatment:HFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | HF mus 4 | Treatment:HFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | HF mus 7 | Treatment:HFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | HF mus 8 | Treatment:HFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | HF plasma 1 | Treatment:HFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | HF plasma 2 | Treatment:HFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | HF plasma 3 | Treatment:HFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | HF plasma 4 | Treatment:HFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | HF plasma 7 | Treatment:HFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | HF plasma 8 | Treatment:HFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | LF epi 1 | Treatment:LFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | LF epi 2 | Treatment:LFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | LF epi 3 | Treatment:LFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | LF epi 6 | Treatment:LFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | LF epi 7 | Treatment:LFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | LF epi 8 | Treatment:LFD | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | LF Hypo 1 | Treatment:LFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | LF Hypo 2 | Treatment:LFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | LF Hypo 3 | Treatment:LFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | LF Hypo 6 | Treatment:LFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | LF Hypo 7 | Treatment:LFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | LF Hypo 8 | Treatment:LFD | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | LF liv 1 | Treatment:LFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | LF liv 2 | Treatment:LFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | LF liv 3 | Treatment:LFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | LF liv 6 | Treatment:LFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | LF liv 7 | Treatment:LFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | LF liv 8 | Treatment:LFD | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | LF mus 1 | Treatment:LFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | LF mus 2 | Treatment:LFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | LF mus 3 | Treatment:LFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | LF mus 6 | Treatment:LFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | LF mus 7 | Treatment:LFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | LF mus 8 | Treatment:LFD | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | LF plasma 1 | Treatment:LFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | LF plasma 2 | Treatment:LFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | LF plasma 3 | Treatment:LFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | LF plasma 6 | Treatment:LFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | LF plasma 7 | Treatment:LFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | LF plasma 8 | Treatment:LFD | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | SW epi 2 | Treatment:SW | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | SW epi 3 | Treatment:SW | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | SW epi 4 | Treatment:SW | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | SW epi 5 | Treatment:SW | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | SW epi 7 | Treatment:SW | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | SW epi 8 | Treatment:SW | Tissue Type:Adipose | nM |
| ESI positive ion mode (Ceramide analysis) | SW Hypo 2 | Treatment:SW | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | SW Hypo 3 | Treatment:SW | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | SW Hypo 4 | Treatment:SW | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | SW Hypo 5 | Treatment:SW | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | SW Hypo 7 | Treatment:SW | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | SW Hypo 8 | Treatment:SW | Tissue Type:Hypothalmus | nM |
| ESI positive ion mode (Ceramide analysis) | SW liv 2 | Treatment:SW | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | SW liv 3 | Treatment:SW | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | SW liv 4 | Treatment:SW | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | SW liv 5 | Treatment:SW | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | SW liv 7 | Treatment:SW | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | SW liv 8 | Treatment:SW | Tissue Type:Liver | nM |
| ESI positive ion mode (Ceramide analysis) | SW mus 2 | Treatment:SW | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | SW mus 3 | Treatment:SW | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | SW mus 4 | Treatment:SW | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | SW mus 5 | Treatment:SW | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | SW mus 7 | Treatment:SW | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | SW mus 8 | Treatment:SW | Tissue Type:Muscle | nM |
| ESI positive ion mode (Ceramide analysis) | SW plasma 2 | Treatment:SW | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | SW plasma 3 | Treatment:SW | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | SW plasma 4 | Treatment:SW | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | SW plasma 5 | Treatment:SW | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | SW plasma 7 | Treatment:SW | Tissue Type:Plasma | nM |
| ESI positive ion mode (Ceramide analysis) | SW plasma 8 | Treatment:SW | Tissue Type:Plasma | nM |
Return to study ST000257 main page
Download data matrix(NIH WCMC Pilot & Feasibility Project: Metabolite changes associated with weight loss ESI negative ion mode ( Oxylipins analysis))
Download data matrix(NIH WCMC Pilot & Feasibility Project: Metabolite changes associated with weight loss ESI positive ion mode (Endocannabinoid analysis))
Download data matrix(NIH WCMC Pilot & Feasibility Project: Metabolite changes associated with weight loss ESI positive ion mode (Ceramide analysis))
- Metabolomics Workbench
|